Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2007 AND VI 21 AND IP 6
Results: 8
1
2
Long-Acting Formulations of Atypical Antipsychotics: Time to Reconsider When to Introduce Depot Antipsychotics.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 441, doi. 10.2165/00023210-200721060-00001
- By:
- Publication type:
- Article
3
Selegiline Transdermal System in Major Depressive Disorder1: Profile Report.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 521, doi. 10.2165/00023210-200721060-00007
- By:
- Publication type:
- Article
4
Oral Disease-Modifying Treatments for Multiple Sclerosis: The Story So Far.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 483, doi. 10.2165/00023210-200721060-00005
- By:
- Publication type:
- Article
5
Mood and Anxiety Disorders in Patients with Myasthenia Gravis: Aetiology, Diagnosis and Treatment.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 473, doi. 10.2165/00023210-200721060-00004
- By:
- Publication type:
- Article
6
Assessing the Role of Drugs in Suicidal Ideation and Suicidality.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 463, doi. 10.2165/00023210-200721060-00003
- By:
- Publication type:
- Article
7
Effect of HMG-CoA Reductase Inhibitors on β-Amyloid Peptide Levels: Implications for Alzheimer’s Disease.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 449, doi. 10.2165/00023210-200721060-00002
- By:
- Publication type:
- Article
8
Impact of Psychotropic Medications on Simulated Driving: A Critical Review.
- Published in:
- CNS Drugs, 2007, v. 21, n. 6, p. 503, doi. 10.2165/00023210-200721060-00006
- By:
- Publication type:
- Article